Free Trial

Bokf Na Has $4.58 Million Stake in Cigna Group $CI

Cigna Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Bokf Na reduced its position in Cigna by 20.3% in Q4, selling 4,226 shares and leaving 16,636 shares valued at about $4.58 million.
  • Insider sales: Nicole S. Jones sold 2,307 shares and Everett Neville sold 1,719 shares at about $288.91 each (roughly $1.16M combined), leaving insiders with approximately 0.60% ownership.
  • Company performance and outlook: Cigna beat quarterly earnings and revenue, set FY2026 EPS guidance around 30.35, carries a consensus "Moderate Buy" target of $338.35, and declared a $1.56 quarterly dividend (2.2% yield).
  • MarketBeat previews the top five stocks to own by June 1st.

Bokf Na decreased its position in Cigna Group (NYSE:CI - Free Report) by 20.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,636 shares of the health services provider's stock after selling 4,226 shares during the quarter. Bokf Na's holdings in Cigna Group were worth $4,579,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. OLD National Bancorp IN boosted its stake in shares of Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider's stock valued at $284,000 after buying an additional 37 shares during the period. Leavell Investment Management Inc. boosted its stake in shares of Cigna Group by 3.8% in the third quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider's stock valued at $318,000 after buying an additional 40 shares during the period. Physician Wealth Advisors Inc. boosted its stake in shares of Cigna Group by 1.5% in the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider's stock valued at $782,000 after buying an additional 41 shares during the period. Cookson Peirce & Co. Inc. boosted its stake in shares of Cigna Group by 0.8% in the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider's stock valued at $1,428,000 after buying an additional 41 shares during the period. Finally, Signet Financial Management LLC boosted its stake in shares of Cigna Group by 0.6% in the third quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider's stock valued at $2,150,000 after buying an additional 41 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company's stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on CI. Truist Financial boosted their price target on Cigna Group from $320.00 to $350.00 and gave the company a "buy" rating in a research note on Tuesday, February 17th. Piper Sandler cut their price target on Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. Jefferies Financial Group cut their price target on Cigna Group from $333.00 to $330.00 and set a "buy" rating for the company in a research note on Monday, April 20th. Robert W. Baird set a $337.00 price target on Cigna Group in a research note on Friday, May 1st. Finally, Royal Bank Of Canada boosted their price target on Cigna Group from $333.00 to $337.00 and gave the company an "outperform" rating in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $338.35.

View Our Latest Report on Cigna Group

Cigna Group Stock Up 2.3%

NYSE CI opened at $282.01 on Thursday. The business has a fifty day moving average price of $274.22 and a two-hundred day moving average price of $276.43. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The stock has a market capitalization of $74.60 billion, a PE ratio of 11.95, a PEG ratio of 0.96 and a beta of 0.30.

Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. During the same period in the prior year, the company earned $6.74 earnings per share. The company's quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts expect that Cigna Group will post 30.4 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio is presently 26.45%.

About Cigna Group

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines